An Assessment of Early Response to Targeted Therapy via Molecular Imaging: A Pilot Study of 3′-deoxy-3′[(18)F]-Fluorothymidine Positron Emission Tomography (18)F-FLT PET/CT in Prostate Adenocarcinoma

Fluorothymidine is a thymidine analog labeled with fluorine-18 fluorothymidine for positron emission tomography ((18)F-FLT-PET) imaging. Thymidine is a nucleic acid that is used to build DNA. Fluorine-18 fluorothymidine ((18)F-FLT) utilizes the same metabolic pathway as does thymidine but has a very...

Descripción completa

Detalles Bibliográficos
Autores principales: Kairemo, Kalevi, Ravizzini, Gregory C., Macapinlac, Homer A., Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489940/
https://www.ncbi.nlm.nih.gov/pubmed/28375169
http://dx.doi.org/10.3390/diagnostics7020020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489940/
https://www.ncbi.nlm.nih.gov/pubmed/28375169
http://dx.doi.org/10.3390/diagnostics7020020

Ejemplares similares